...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Free
Message: RESVERLOGIX ANNOUNCES. $15.1 MILLION OF PRIVATE PLACEMENTS

Is probably more that $7.5 million still owing,... as the initial loan was $30 million USD

Share
New Message
Please login to post a reply